UNSPSC 85761351: Insertion of radioactive element into female perineum, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of radioactive element into female perineum, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0WHN31Z

UNSPSC 85761351 Insertion of radioactive element into female perineum, percutaneous approach is a Commodity code that shows a fundamental mismatch between its clinical procedure scope and recent state and local procurement activity. The six opportunities posted since July 2026 do not include any solicitations for radioactive brachytherapy or related oncology intervention services. Instead, the opportunities sourced under this code cover occupational medical surveillance, pharmacy benefit management, disability medical evaluations, surgical carve-out networks, youth detention healthcare, and temporary health professional staffing — none of which align with the code's stated clinical definition. This signal suggests either a data-tagging error in the procurement platform or a code classification that state and local buyers are not using to solicit work within its nominal scope.

The recent opportunities span Arizona, California, Florida, and Washington, issued by a city retirement office (Phoenix), municipal health agencies (Long Beach, Santa Clara County), a state transportation department (Washington), a county juvenile probation department (Harris County, Texas), and a county human resources and benefits consortium (Collier County, Florida). No pattern of repeat buyers or geographic concentration emerges from the sample. Given the absence of any radioactive medical procedure solicitations in the block and the administrative or staffing nature of all opportunities present, this code does not appear to support active state and local procurement for the clinical service it nominally describes. Prospective vendors focused on brachytherapy, cancer treatment, or related oncology interventions should monitor procurement channels directly rather than relying on this code classification.